Literature DB >> 11839789

The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium.

Thomas Tawadros1, Andrea Formenton, Jean Dudler, Nancy Thompson, Pascal Nicod, Hans-Jürg Leisinger, Gérard Waeber, Jacques-Antoine Haefliger.   

Abstract

The c-Jun N-terminal kinase (JNK) is critical for cell survival, differentiation, apoptosis and tumorigenesis. This signalling pathway requires the presence of the scaffold protein Islet-Brain1/c-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1). Immunolabeling and in situ hybridisation of bladder sections showed that IB1/JIP-1 is expressed in urothelial cells. The functional role of IB1/JIP-1 in the urothelium was therefore studied in vivo in a model of complete rat bladder outlet obstruction. This parietal stress, which is due to urine retention, reduced the content of IB1/JIP-1 in urothelial cells and consequently induced a drastic increase in JNK activity and AP-1 binding activity. Using a viral gene transfer approach, the stress-induced activation of JNK was prevented by overexpressing IB1/JIP-1. Conversely, the JNK activity was increased in urothelial cells where the IB1/JIP-1 content was experimentally reduced using an antisense RNA strategy. Furthermore, JNK activation was found to be increased in non-stressed urothelial cells of heterozygous mice carrying a selective disruption of the IB1/JIP-1 gene. These data established that mechanical stress in urothelial cells in vivo induces a robust JNK activation as a consequence of regulated expression of the scaffold protein IB1/JIP-1. This result highlights a critical role for that scaffold protein in the homeostasis of the urothelium and unravels a new potential target to regulate the JNK pathway in this tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839789     DOI: 10.1242/jcs.115.2.385

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  A unique set of SH3-SH3 interactions controls IB1 homodimerization.

Authors:  Ole Kristensen; Sylvie Guenat; Imran Dar; Nathalie Allaman-Pillet; Amar Abderrahmani; Mourad Ferdaoussi; Raphaël Roduit; Fabienne Maurer; Jacques S Beckmann; Jette S Kastrup; Michael Gajhede; Christophe Bonny
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

2.  Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells.

Authors:  A Abderrahmani; G Niederhauser; D Favre; S Abdelli; M Ferdaoussi; J Y Yang; R Regazzi; C Widmann; G Waeber
Journal:  Diabetologia       Date:  2007-04-17       Impact factor: 10.122

3.  Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase.

Authors:  Jon Schoorlemmer; Mitchell Goldfarb
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

Review 4.  ATM and ATR: sensing DNA damage.

Authors:  Jun Yang; Zheng-Ping Xu; Yun Huang; Hope E Hamrick; Penelope J Duerksen-Hughes; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

5.  Disassembly of the JIP1/JNK molecular scaffold by caspase-3-mediated cleavage of JIP1 during apoptosis.

Authors:  Mahesh Vaishnav; Marion MacFarlane; Martin Dickens
Journal:  Exp Cell Res       Date:  2011-01-13       Impact factor: 3.905

6.  Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death.

Authors:  David B Parkinson; Ambily Bhaskaran; Anna Droggiti; Sarah Dickinson; Maurizio D'Antonio; Rhona Mirsky; Kristjan R Jessen
Journal:  J Cell Biol       Date:  2004-02-02       Impact factor: 10.539

7.  Autophagy-related gene expression is an independent prognostic indicator of glioma.

Authors:  Huixue Zhang; Xiaoyan Lu; Ning Wang; Jianjian Wang; Yuze Cao; Tianfeng Wang; Xueling Zhou; Yang Jiao; Lei Yang; Xiaokun Wang; Lin Cong; Jianlong Li; Jie Li; He-Ping Ma; Yonghui Pan; Shangwei Ning; Lihua Wang
Journal:  Oncotarget       Date:  2017-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.